Blue Whale Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.6M Buy
404,200
+95,733
+31% +$13.4M 2.26% 15
2025
Q4
$50.5M Buy
308,467
+65,366
+27% +$10.2M 2.59% 15
2025
Q3
$32.5M Sell
243,101
-44,585
-15% -$5.42M 1.8% 19
2025
Q2
$35.8M Buy
+287,686
New +$36.6M 2.34% 16

Other funds holding RGEN

Blue Whale Capital's RGEN Position: Q1 2026 in Review

Blue Whale Capital increased its Repligen (RGEN) stake by 31% in Q1 2026, buying an estimated $13.4M and bringing the position to 404,200 shares worth $47.6M. The position accounts for 2.26% of the portfolio, ranked #15.

Blue Whale Capital first reported a position in RGEN in Q2 2025 and has held it in 4 quarters since. The position peaked at $50.5M in Q4 2025. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Blue Whale Capital held 404,200 shares of Repligen worth $47.6M as of Q1 2026.
  • Blue Whale Capital bought 95,733 Repligen shares in Q1 2026, an estimated $13.4M.
  • Repligen made up 2.26% of Blue Whale Capital's portfolio in Q1 2026, its #15 holding.
  • Blue Whale Capital first reported a position in Repligen in Q2 2025 and has held it in 4 quarters since.
  • Blue Whale Capital's Repligen position peaked at $50.5M in Q4 2025.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Blue Whale Capital's 13F filing for Q1 2026, filed 14 May 2026.